Antimicrobial Agents and Chemotherapy · 2001 · 64 citations · 21 references
PharmacyPharmacokineticsPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyClinical PharmacologyPharmaceutical StabilityPharmacokinetics In Critical IllnessPharmacokinetics Of AntimicrobialsStability Of Pharmaceutical FormulationsContinuous Infusion AntibioticsContinuous Infusion PharmacologyNosocomial PneumoniaPneumonia Antibiotic TherapySevere Pneumonia ManagementValproic Acid
The stability and compatibility of ceftazidime have been examined in the context of its potential use in concentrated solutions for continuous infusion in patients suffering from severe nosocomial pneumonia and receiving other intravenous medications by the same route. Ceftazidime stability in 4 to 12% solutions was found satisfactory (<10% degradation) for 24 h if kept at a temperature of 25 degrees C (77 degrees F) maximum. Studies mimicking the simultaneous administration of ceftazidime and other drugs as done in clinics showed physical incompatibilities with vancomycin, nicardipine, midazolam, and propofol and a chemical incompatibility with N-acetylcystein. Concentrated solutions (50 mg/ml) of erythromycin or clarithromycin caused the appearance of a precipitate, whereas gentamicin, tobramycin, amikacin, isepamicin, fluconazole, ketamine, sufentanil, valproic acid, furosemide, uradipil, and a standard amino acid solution were physically and chemically compatible.
21